| related words |
| investigator |
| nda |
| novel |
| flavor |
| glumetza |
| auxilium |
| zegerid |
| patented |
| capsule |
| tm |
| xr |
| tarceva |
| factive |
| immunotherapy |
| investigational |
| myvax |
| stent |
| oral |
| discovering |
| savella |
|
| related documents |
| 1125001--3/24/2006--IOMAI_CORP |
| 1333248--3/28/2007--CADENCE_PHARMACEUTICALS_INC |
| 67494--6/2/2006--PIERRE_FOODS_INC |
| 67494--6/16/2008--PIERRE_FOODS_INC |
| 1333248--3/13/2008--CADENCE_PHARMACEUTICALS_INC |
| 1322505--12/14/2010--Biodel_Inc |
| 67494--6/15/2007--PIERRE_FOODS_INC |
| 1172480--3/6/2009--SANTARUS_INC |
| 1123979--2/14/2008--SENOMYX_INC |
| 1157601--3/28/2007--SYNTA_PHARMACEUTICALS_CORP |
| 881524--3/10/2010--VIVUS_INC |
| 1180145--3/27/2007--REPLIDYNE_INC |
| 69680--3/26/2007--NASHUA_CORP |
| 873364--2/28/2007--CEPHALON_INC |
| 873364--2/12/2010--CEPHALON_INC |
| 1062216--3/31/2006--MEMORY_PHARMACEUTICALS_CORP |
| 707511--4/15/2009--REGENERX_BIOPHARMACEUTICALS_INC |
| 1157601--3/26/2009--SYNTA_PHARMACEUTICALS_CORP |
| 1123979--2/12/2009--SENOMYX_INC |
| 873364--2/23/2009--CEPHALON_INC |
|
| related topics |
| {product, candidate, development} |
| {property, intellectual, protect} |
| {capital, credit, financial} |
| {gas, price, oil} |
| {loss, insurance, financial} |
| {acquisition, growth, future} |
| {financial, litigation, operation} |
| {product, liability, claim} |
| {system, service, information} |
| {investment, property, distribution} |
| {condition, economic, financial} |
| {stock, price, operating} |
| {cost, contract, operation} |
| {product, market, service} |
| {operation, international, foreign} |
| {competitive, industry, competition} |
| {cost, regulation, environmental} |
| {tax, income, asset} |
| {customer, product, revenue} |
| {interest, director, officer} |
|